As of April 2025 Roche has a market cap of NZ$410.20 Billion. This makes Roche the world's 44th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$410.20 B | 2.55% |
2024 | NZ$400.02 B | 8.08% |
2023 | NZ$370.09 B | -9.47% |
2022 | NZ$408.80 B | -22.36% |
2021 | NZ$526.52 B | 26.97% |
2020 | NZ$414.68 B | 1.06% |
2019 | NZ$410.33 B | 30.67% |
2018 | NZ$314.02 B | 3.8% |
2017 | NZ$302.54 B | 7.06% |
2016 | NZ$282.58 B | -18.88% |
2015 | NZ$348.34 B | 17.82% |
2014 | NZ$295.66 B | 2.02% |
2013 | NZ$289.80 B | -24.43% |
2012 | NZ$383.47 B | 103.16% |
2011 | NZ$188.75 B | 14.26% |
2010 | NZ$165.19 B | -19.39% |
2009 | NZ$204.94 B | -12.12% |
2008 | NZ$233.21 B | 17.91% |
2007 | NZ$197.78 B | -9.83% |
2006 | NZ$219.35 B |
On Apr 11th, 2025 the market cap of Roche was reported to be: